MedPath

SUPRAX - TAB 200MG

SUPRAX - TAB 200MG

Discontinued
DIN Number

02195976

Drug Class

Human

Market Date

Dec 31, 1990

Company
HC

rhone-poulenc rorer canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02195976
AIG Number0122105002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD08 CEFIXIME
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:12.06.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFIXIMEActive
Strength: 200 MG / TAB
Monograph: CEFIXIME

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.